Tomasello Shawn
- SEC CIK
- 0001617239
In the past year, 1 open-market purchase filing worth $50.2K and no sales.
Current role at each company
- FDMT 4D Molecular Therapeutics, Inc.Directoras of Jun 18, 2026
- CABA Cabaletta Bio, Inc.Directoras of Jun 10, 2026
- KLRS Kalaris Therapeutics, Inc.Directoras of Jun 7, 2024
- GMDA Gamida Cell Ltd.Directoras of Feb 2, 2024
- TCRR TCR2 Therapeutics Inc.Directoras of Jun 1, 2023
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- $50.2K
- 1 filing
- Sold
- –
- 0 filings
- Net
- +$50.2K
- Bought minus sold
- Companies
- 1
- With open-market trades
Trades
Every Form 4 that lists Tomasello Shawn as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
CABA Cabaletta Bio, Inc.
Director1 trade
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Jan 21, 2026 (view filing) | Jan 21 | Same day | Tomasello ShawnDirector | PPurchase | +22.7K | $2.21 | +$50.2K | New position22.7K after |
GMDA Gamida Cell Ltd.
Director1 trade
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Oct 4, 2022 (view filing) | Sep 30 | 4 days | Tomasello ShawnDirector | PPurchase | +9.68K | $1.55 | +$15.0K | +483.8%11.7K after |